Hepatocellular Carcinoma Clinical Trials in The Bronx, New York

3 studies are recruiting for hepatocellular carcinoma in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

    This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT204, an investigational ARTEMIS® T-cell therapy, in adult subjects with GPC3-positive hepatocellular carcinoma (HCC) who have experienced disease progression on, or intolerance to, …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Montefiore Einstein Comprehensive Cancer Center, The Bronx, New York
    Locations
    8 in total
    Run by
    Eureka Therapeutics Inc.

    See if you can join NCT04864054 on ClinicalTrials.gov

  2. HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

    This is a pilot and feasibility study assessing the role of quantitative multiparametric MRI and blood-based biomarkers for the measurement of liver function in patients receiving radiation therapy for liver cancer, including hepatocellular carcinoma (HCC), cholangiocarcinoma, or liver metastases r…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Montefiore Medical Center, The Bronx, New York
    Run by
    Montefiore Medical Center

    See if you can join NCT06899152 on ClinicalTrials.gov

  3. Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

    The purpose of this study is to assess the efficacy and safety of RP2 in combination with atezolizumab plus bevacizumab (Cohorts 1a and 1b) and RP2 monotherapy (Cohort 2) in the as second line treatment in patients with locally advanced unresectable, recurrent, and/or metastatic HCC and in combinat…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Montefiore Medical CenterMontefiore Medical Park, The Bronx, New York
    Locations
    12 in total
    Run by
    Replimune, Inc.

    See if you can join NCT05733598 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.